Serum autotaxin levels correlate with hepatic dysfunction and severity in postoperative biliary atresia

References

• A-Kader HH, Abdel-Hameed A, Al-Shabrawi M, et al. (2003). Is biliary atresia an autoimmune disease? Eur J Gastroenterol Hepatol 15:447.
   PubMed Web of Science ®Google Scholar
• Davenport M. (2012). Biliary atresia: clinical aspects. Semin Pediatr Surg 21:175–84
   PubMed Web of Science ®Google Scholar
• Fotopoulou S, Oikonomou N, Grigorieva E, et al. (2010). ATX expression and LPA signalling are vital for the development of the nervous system. Dev Biol 339:451–64
   PubMed Web of Science ®Google Scholar
• Gressner AM, Weiskirchen R. (2006). Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 10:76–99
   PubMed Web of Science ®Google Scholar
• Hartley JL, Davenport M, Kelly DA. (2009). Biliary atresia. Lancet 374:1704–13
   PubMed Web of Science ®Google Scholar
• Ikeda H, Yatomi Y, Yanase M, et al. (1998). Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. Biochem Biophys Res Commun 248:436–40
   PubMed Web of Science ®Google Scholar
• Iwasawa Y, Fujii T, Nagamatsu T, et al. (2009). Expression of autotaxin, an ectoenzyme that produces lysophosphatidic acid, in human placenta. Am J Reprod Immunol 62:90–5
   PubMedGoogle Scholar
• Jansen S, Andries M, Vekemans K, et al. (2009). Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. Cancer Lett 284:216–21
   PubMed Web of Science ®Google Scholar
• Muro H, Shirasawa H, Kosugi I, Nakamura S. (1993). Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis. Am J Pathol 143:105–20
   PubMedGoogle Scholar
• Nakagawa H, Ikeda H, Nakamura K, et al. (2011). Autotaxin as a novel serum marker of liver fibrosis. Clin Chim Acta 412:1201–6
   PubMedGoogle Scholar
• Nakasaki T, Tanaka T, Okudaira S, et al. (2008). Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am J Pathol 173:1566–76
   PubMedGoogle Scholar
• Pleli T, Martin D, Kronenberger B, et al. (2014). Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis – a prospective cohort study. PLoS One 9:e103532
   Google Scholar
• Stefan C, Gijsbers R, Stalmans W, Bollen M. (1999). Differential regulation of the expression of nucleotide pyrophosphatases/phosphodiesterases in rat liver. Biochim Biophys Acta 1450:45–52
   PubMed Web of Science ®Google Scholar
• Stracke ML, Krutzsch HC, Unsworth EJ, et al. (1992). Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 267:2524–9
   PubMed Web of Science ®Google Scholar
• Stracke ML, Clair T, Liotta LA. (1997). Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul 37:135–44
   PubMedGoogle Scholar
• Tanaka M, Okudaira S, Kishi Y, et al. (2006). Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281:25822–30
   PubMed Web of Science ®Google Scholar
• Tokumura A, Majima E, Kariya Y, et al. (2002). Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277:39436–42
   PubMed Web of Science ®Google Scholar
• van Meeteren LA, Ruurs P, Stortelers C, et al. (2006). Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26:5015–22
   PubMed Web of Science ®Google Scholar
• Wai CT, Greenson JK, Fontana RJ, et al. (2003). A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518–26
   PubMed Web of Science ®Google Scholar
• Wallace K, Burt AD, Wright MC. (2008). Liver fibrosis. Biochem J 411:1–18
   PubMed Web of Science ®Google Scholar
• Watanabe N, Ikeda H, Nakamura K, et al. (2007a). Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol 41:616–23
   PubMed Web of Science ®Google Scholar
• Watanabe N, Ikeda H, Nakamura K, et al. (2007b). Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci 81:1009–15
   PubMed Web of Science ®Google Scholar
• Wu JM, Xu Y, Skill NJ, et al. (2010). Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma. Mol Cancer 31:9:71
   Google Scholar
• Yamaoka K, Nouchi T, Marumo F, Satoc C. (1993). Alpha-smooth-muscle actin expression in normal and fibrotic human livers. Dig Dis Sci 38:1473–9
   PubMedGoogle Scholar
• Yuelling LM, Fuss B. (2008). Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties. Biochim Biophys Acta 1781:525–30
   PubMed Web of Science ®Google Scholar